Virginie Olive

1.9k citations
12 papers · 1.5k indexed · h-index 11
Topics
MicroRNA in disease regulation (6 papers)Circular RNAs in diseases (4 papers)Cancer Mechanisms and Therapy (3 papers)
Partner nations
United StatesChinaFrance

In The Last Decade

Virginie Olive

12 papers receiving 1.5k citations

Peers

Virginie Olive
Comparison fields: 5 of 82
  • Molecular Biology 1.1k
  • Cancer Research 1.1k
  • Immunology 219
  • Oncology 120
  • Pathology and Forensic Medicine 96
Replace Jill Magnus with:
Jill Magnus United States
M Bennett United States
David C. Corney United States
Karen D. Cowden Dahl United States
Konstantinos J. Mavrakis United States
Alessandro Gardini United States
Anke Sparmann Germany
Sylvie Thuault France
Yunqing Li China
Björn Bakker Netherlands
Virginie Olive relative to Jill Magnus United States Jill Magnus's profile →
Citations per field
00.5×1.7×
Jill Magnus · 1×
Citations per year

Countries citing papers authored by Virginie Olive

Since Specialization
Citations

This map shows the geographic impact of Virginie Olive's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Virginie Olive with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Virginie Olive more than expected).

Fields of papers citing papers by Virginie Olive

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Virginie Olive. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Virginie Olive. The network helps show where Virginie Olive may publish in the future.

Co-authorship network of co-authors of Virginie Olive

This figure shows the co-authorship network connecting the top 25 collaborators of Virginie Olive. A scholar is included among the top collaborators of Virginie Olive based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Virginie Olive. Virginie Olive is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
#WorkIndexed citations
1 21
2 18
3 38
4 54
5 63
6 124
7 244
8 369
9 492
10 9
11 27
12 28

About Virginie Olive

Virginie Olive is a scholar working on Cancer Research, Reproductive Medicine and Pathology and Forensic Medicine, having authored 12 papers that have together received 1.5k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (6 papers), Circular RNAs in diseases (4 papers) and Cancer Mechanisms and Therapy (3 papers). The work is most often cited by research in Cancer Research (1.1k citations), Molecular Biology (1.1k citations) and Immunology (219 citations). Virginie Olive has collaborated with scholars based in United States, China and France. Frequent co-authors include Lin He, Iris Jiang, Qi-Jing Li, M Bennett, Cong Ma, James C. Walker, Scott W. Lowe, Gregory J. Hannon, Carlos Cordon‐Cardo and Qijing Li. Their work appears in journals such as Proceedings of the National Academy of Sciences, Genes & Development and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026